This is female nomination
Because of the particular specificity of products presented in this category, an objective evaluation and comment on the nominees is only allowed for women. Men can only see the results.
This is female nomination
Results
Experts Jury survey results of 2016 in category
Pharmaceuticals with no prescription / Medication for female intimate health
1.
3
Вагілак (Pharmascience)Link 57.14% 5
 
2.
3
Vagisan (Ядран – Галенська Лабораторія д.д.) Absolute Favorite – 2016 Link 28.57% 2.50
 
2.
1
Gynoflor (Delta Medical)Link 28.57% 2.50
 
4.
~
Bioselac (Rotapharm)Link 14.29% 1.25
 
4. Gynodek (YURiA-PHARM)Link 14.29% 1.25
 
4.
2
Gynolakt (Teva)Link 14.29% 1.25
 
4. Tantum Rosa (DILEO Farma Ukraine)Link 14.29% 1.25
 
View results of current, 2024 year  Show all preparations

Normed consumer's score are calculated by 5-score scale, accordingly to the methodic of the research.
Notice
The participant which took the 1st place in this rating is by opinion of industry specialists is the best choice in 2016, recommendation of an experts #1 in the category “Medication for female intimate health”.
Using this rating is only possible with obligatory link to the source.
This rating was built as a result of the study of social preferences in 2016, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.  Details…
Comments(0)
all in a row | positive | negative

No comments yet… Be the first to leave comment on this topic!

or
You may sign in using:
Enter with Facebook Enter with Google Enter with VK
Aye Nay
  

Achtung! Please be polite! Although that modertors of this web-portal are excessively democratic, any unethical, unqotable or just rude expressions, which abuse other visitors of this web site, can be deleted. Also will be deleted any spam and public comments with private phone numbers.